Possible role of sertraline against 3-nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunctions in rat brain

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 1, 2009, Pages 100-108

  Kumar, Puneet ^a   Kumar, Anil ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

3 Nitropropionic acid; Huntington's disease; Mitochondrial dysfunction; Oxidative stress; Reactive oxygen species; Sertraline

Indexed keywords

3 NITROPROPIONIC ACID; ANTIOXIDANT; NITRITE; REACTIVE OXYGEN METABOLITE; SERTRALINE; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIORAL STRESS; BODY WEIGHT; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUNTINGTON CHOREA; LIPID PEROXIDATION; LOCOMOTION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; ROTAROD TEST;

ANIMALS; ANTIOXIDANTS; BODY WEIGHT; BRAIN; CEREBRAL CORTEX; CORPUS STRIATUM; HIPPOCAMPUS; MALE; MITOCHONDRIA; MOTOR ACTIVITY; NITRO COMPOUNDS; OXIDATIVE STRESS; PROPIONIC ACIDS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; ROTAROD PERFORMANCE TEST; SERTRALINE; YOHIMBINE;

EID: 58149345547     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.10.013     Document Type: Article

References (54)

1. Akashiba H., Ikegaya Y., Nishiyama N., and Matsuki N. Differential involvement of cell cycle reactivation between striatal and cortical neurons in cell death induced by 3-nitropropionic acid. J Biol Chem 283 10 (2008) 6594-6606
2. Beal M.F. Mitochondrial dysfunction in neurodegenerative diseases. Biochim Biophys Acta 1366 (1998) 211-223
3. Beal M.F., Brouillet E., Jenkins B.G., Ferrante R.J., Kowall N.W., Miller J.M., et al. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13 (1993) 4181-4192
4. Berman S.B., and Hastings T.G. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease. J Neurochem 73 (1999) 1127-1137
5. Bianchi M.T. Non-serotonin anti-depressant actions: direct ion channel modulation by SSRIs and the concept of single agent poly-pharmacy. Med Hypotheses 70 5 (2008) 951-956
6. Borlongan C.V., Kanning K., Poulos S.G., Freeman T.B., Cahill D.W., and Sanberg P.R. Free radical damage and oxidative stress in Huntington's disease. J Fla Med Assoc 83 5 (1996) 335-341
7. Brouillet E., Jacquard C., Bizat N., and Blum D. 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease. J Neurochem 95 6 (2005) 1521-1540
8. Browne S.E., Ferrante R.J., and Beal M.F. Oxidative stress in Huntington's disease. Brain Pathol 9 (1999) 147-163
9. Duan W., Peng Q., Masuda N., Ford E., Tryggestad E., Ladenheim B., et al. Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease. Neurobiol Dis 30 3 (2008) 312-322
10. Duman R.S. Novel therapeutic approaches beyond the serotonin receptor. Biol Psychiatry 44 5 (1998) 324-335
11. Eren I., Naziroǧlu M., and Demirdaş A. Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain. Neurochem Res 32 7 (2007) 1188-1195
12. Eren I., Naziroǧlu M., and Demirdaş A. Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat. Neurochem Res 32 3 (2007) 497-505
13. Fu Y., et al. 3-Nitropropionic acid produces indirect excitotoxic damage to rat striatum. Neurotoxicol Teratol 17 3 (1995) 333-339
14. Goggi J., Pullar I.A., Carney S.L., and Bradford H.F. Modulation of neurotransmitter release induced by brain-derived neurotrophic factor in rat brain striatal slices in vitro. Brain Res 941 1-2 (2002) 34-42
15. Gornall A.G., Bardawill C.J., and David M.M. Determination of serum proteins by means of the biuret reaction. J Biol Chem 177 (1949) 751-766
16. 15N] nitrate in biological fluids. Ann Biochem 126 (1982) 131-138
17. Guyot M.C., Palfi S., Stutzmann J.M., Mazière M., Hantraye P., and Brouillet E. Riluzole protects from motor deficits and striatal degeneration produced by systemic 3-nitropropionic acid intoxication in rats. Neuroscience 81 1 (1997) 141-149
18. King J. Colorimetric estimation of lactate dehydrogenase. J Med Lab Technol 16 (1959) 256-261
19. King T.E. Preparation of succinate dehydrogenase and reconstitution of succinate oxidase. Methods Enzymol 10 (1967) 322-331
20. King T.E., and Howard R.L. Preparations and properties of soluble NADH dehydrogenases from cardiac muscle. Methods Enzymol 10 (1967) 275-294
21. Kono Y. Generation of superoxide radical during auto-oxidation of hydroxylamine and an assay of superoxide dismutase. Arch Biochem biophys 186 (1978) 189-195
22. Kulkarni S.K. Handbook of experimental pharmacology. 3rd edition (1999), Vallabh Parkashan, New Delhi, India
23. Kumar P., Padi S.S., Naidu P.S., and Kumar A. Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms. Behav Pharmacol 17 5-6 (2006) 485-492
24. Kumar P., Padi S.S., Naidu P.S., and Kumar A. Possible neuroprotective mechanisms of curcumin in attenuating 3-nitropropionic acid-induced neurotoxicity. Methods Find Exp Clin Pharmacol 29 (2007) 1-7
25. Luck H. Catalase. In: Bergmeyer H.U. (Ed). Methods of enzymatic analysis (1971), Academic Press, New York 885-893
26. Maher P., and Davis J.B. The role of monoamine metabolism in oxidative glutamate toxicity. J Neurosci 16 (1996) 6394-6401
27. Malberg J.E., and Blendy J.A. Antidepressant action: to the nucleus and beyond. Trends Pharmacol Sci 26 12 (2005) 631-638
28. Montilla P., Tunez I., Munoz M.C., Salcedo M., Feijoo M., Munoz-Castaneda J.R., et al. Effect of glucocorticoids on 3-nitropropionic acid-induced oxidative stress in synaptosomes. Eur J Pharmacol 488 (2004) 19-25
29. Mosmann T. Rapid colorimetric assay for cellular growth survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 (1983) 55-63
30. Muñoz-Castañeda J.R., Montilla P., Padillo F.J., Bujalance I., Muñoz M.C., Muntané J., and Túnez I. Role of serotonin in cerebral oxidative stress in rats. Acta Neurobiol Exp (Wars) 66 1 (2006) 1-6
31. Nair A., and Vaidya V.A. Cyclic AMP response element binding protein and brain-derived neurotrophic factor: molecules that modulate our mood?. J Biosci 31 3 (2006) 423-434
32. Nam E., Lee S.M., Koh S.E., Joo W.S., Maeng S., Im H.I., et al. Melatonin protects against neuronal damage induced by 3-nitropropionic acid in rat striatum. Brain Res 1046 (2005) 90-96
33. Nibuya M., Morinobu S., and Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15 11 (1995) 7539-7547
34. Nibuya M., Nestler E.J., and Duman R.S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 16 7 (1996) 2365-2372
35. Nieuwstraten C., Labiris N.R., and Holbrook A. Systematic overview of drug interactions with antidepressant medications. Can J Psychiatry 51 (2006) 300-316
36. Nunez M.J., Balboa J., Rodrigo E., Brenlla J., Gonzalez-Peteiro M., and Freire-Garabal M. Effects of fluoxetine on cellular immune response in stressed mice. Neurosci Lett 396 (2006) 247-251
37. Pandey M., Varghese M., Sindhu K.M., Sreetama S., Navneet A.K., Mohanakumar K.P., et al. Mitochondrial NAD+-linked State 3 respiration and complex-I activity are compromised in the cerebral cortex of 3-nitropropionic acid-induced rat model of Huntington's disease. J Neurochem 104 2 (2008) 420-434
38. Pedrazzaa E.L., Mario R.S., Pedrazzaa L., Zimmermanna F.F., Sarkisb J.J.F., and Bonan C.D. Sertraline and clomipramine inhibit nucleotide catabolism in rat brain synaptosomes. Toxicol in Vitro 21 4 (2007) 671-676
39. Peng Q., Masuda N., Jiang M., Li Q., Zhao M., Ross C.A., and Duan W. The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington's disease mouse model. Exp Neurol 210 1 (2008) 154-163
40. Ranen N.G., Lipsey J.R., Treisman G., and Ross C.A. Sertraline in the treatment of severe aggressiveness in Huntington's disease. J Neuropsychiatry Clin Neurosci 8 3 (1996) 338-340 Summer
41. Reddy D.S., and Kulkarni S.K. Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging and dizociline induced leaning impairment. Brain Res 799 (1998) 215-219
42. Schmidt H.D., and Duman R.S. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol 18 5-6 (2007) 391-418
43. Shinomol G.K., and Muralidhara. Effect of Centella asiatica leaf powder on oxidative markers in brain regions of prepubertal mice in vivo and its in vitro efficacy to ameliorate 3-NPA-induced oxidative stress in mitochondria. Phytomedicine (2008) 10.1016/j.phymed.2008.04.010
44. Sills T.L., Greenshaw A.J., Baker G.B., and Fletcher P. The potentiating effect of sertraline and fluoxetine on amphetamine-induced locomotor activity is not mediated by serotonin. Psychopharmacologia 143 4 (1999) 426-432
45. Silva-Adaya D., Pérez-De La Cruz V., Herrera-Mundo M.N., Mendoza-Macedo K., Villeda-Hernández J., Binienda Z., et al. Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of l-carnitine. J Neurochem 105 3 (2008) 677-689
46. Sottocasa G.L., Kuylenstierna B., Ernster L., and Bergstrand A. An electron-transport system associated with the outer membrane of liver mitochondria. A biochemical and morphological study. J Cell Biol 32 (1967) 415-438
47. Takuma K., Baba A., and Matsuda T. Astrocyte apoptosis: implications for neuroprotection. Prog Neurobiol 72 (2004) 111-127
48. Tardito D., Perez J., Tiraboschi E., Musazzi L., Racagni G., and Popoli M. Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview. Pharmacol Rev 58 1 (2006) 115-134
49. Tariq M., Khan H.A., Elfaki I., Al Deeb S., and Al Moutaery K. Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats. Brain Res Bull 67 (2005) 161-168
50. Túnez I., Feijóo M., Collado J.A., Medina F.J., Peña J., Muñoz Mdel C., et al. Effect of testosterone on oxidative stress and cell damage induced by 3-nitropropionic acid in striatum of ovariectomized rats. Life Sci 80 13 (2007) 1221-1227
51. Villarán R.F., Tomás-Camardiel M., de Pablos R.M., Santiago M., Herrera A.J., Navarro A., et al. Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production. Neurotoxicology 29 2 (2008) 244-258
52. Wills E.D. Mechanism of lipid peroxide formation in animal. Biochem J 99 (1966) 667-676
53. Zafir A., and Banu N. Antioxidant potential of fluoxetine in comparison to Curcuma longa in restraint-stressed rats. Eur J Pharmacol 572 1 (2007) 23-31
54. Zhang W.H., Wang H., Wang X., Narayanan M.V., Stavrovskaya I.G., Kristal B.S., and Friedlander R.M. Nortriptyline protects mitochondria and reduces cerebral ischemia/hypoxia injury. Stroke 39 2 (2008) 455-462